Merck to pay Gilead $14m in attorneys’ fees
20-07-2017
Judge overturns $200m award in Gilead v Merck
09-06-2016
Merck handed $200m in Gilead hepatitis C row
29-03-2016
Merck claims hepatitis C patent win
23-03-2016
Gil C / Shutterstock.com
A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck, Gilead, hepatitis C, patent infringement, damages, patent, Harvoni, Sovaldi, US District Court for the Northern District of California
